Emcure Pharmaceuticals IPO Day 2: GMP, subscription status, and review of allotment date. Apply or not?

Emcure Pharmaceuticals IPO Day 2: GMP, subscription status, and review of allotment date. Apply or not?

Emcure Pharmaceuticals IPO: Bidding for the initial public offering (IPO) began on July 3, 2024, and will stay open until July 5, 2024. This implies the public issue will be open until Friday this week. Emcure Pharmaceuticals’ IPO price ranges from ₹960 to ₹1008 per equity share. According to the Emcure Pharmaceuticals IPO subscription status,…

Read More
Paras Defence shares surge 20% to a one-year high

Paras Defence shares surge 20% to a one-year high; will this powerful upward trend continue?

Paras Defence and Space Technologies Ltd witnessed a remarkable surge of 20 percent, reaching a new 52-week high of Rs 1,157.25 during Friday’s trading session. With this surge, the stock, considered a multi-bagger, has recorded a remarkable gain of 109.19 % over the last year. Today, a significant number of defense-related stocks experienced a notable…

Read More
Suzlon Energy shares: Nuvama begins covering the stock

Suzlon Energy shares: Nuvama begins covering the stock and projects a 20% gain in upside potential

Suzlon Energy shares: Nuvama Institutional Equities has recently started covering Suzlon Energy, expressing a favorable view towards the renewable energy company. They perceive Suzlon as the frontrunner in the wind energy sector, holding a dominant position. Aligning with other local brokerages, Nuvama foresees a potential 20% increase in Suzlon Energy’s stock value. With the energy…

Read More